Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-17

Clinical Trial Update: Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy [Phase 4]

View source ↗

Summary

This document provides extended follow-up data from a Phase 4 study of prednisone plus cyclophosphamide in patients with advanced IgA nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • PREDNISONE (Prednisone)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: IgA Nephropathy | Phase 4 | Status: UNKNOWN